The cell-penetrating peptide (CPP) penetratin, has demonstrated potential as a carrier for transepithelial delivery of cargo peptides, such as the therapeutically relevant part of parathyroid hormone, i.e. PTH(1-34).
INTRODUCTION
Peptide drug entities are of high therapeutic interest due to their potency and specific mode of action, and an increasing number of these drugs currently enter production lines in the pharmaceutical industry. A major obstacle in the successful implementation of peptide drugs, and biopharmaceuticals in general, is that their administration to a large extent is limited to invasive routes; often experienced as inconvenient and potentially leading to poor patient compliance. When pharmacologically relevant, oral administration of a peptide drug may thus, be pursued. However, sufficient delivery of peptide drugs via the gastrointestinal tract is limited by poor enzymatic stability and large molecular size, the latter hindering non-aided permeation across the intestinal epithelium. Nevertheless, the class of membrane interacting peptides termed cell-penetrating peptides (CPPs) has demonstrated promising potential as carriers for transepithelial delivery of cargo peptides. 1 In order to enhance the transepithelial permeation of a cargo peptide using CPPs, coadministration with a CPP in a physical mixture [2] [3] [4] or conjugation to a CPP 5 may be pursued. 6 The latter approach ensures an inherent proximity of the two molecules, but may negatively affect the biological activity of the therapeutic cargo as well as the delivery propensity of the CPP. On the other hand, by using the co-administration approach one may obtain a pool of poorly defined CPP-cargo complexes due to electrostatic and/or hydrophobic interactions between the CPP and the cargo moiety. A previous study demonstrated that conjugation of the CPP, penetratin, to the biologically active part of parathyroid hormone (PTH(1-34)) negatively affected the potency of PTH . 7 In addition, the ability of penetratin to enhance PTH(1-34) permeation across an intestinal epithelium in vitro was more effective when co-administered with PTH(1-34) as compared to covalently conjugated to PTH(-34) at the same molar ratios. 8 Using the coadministration approach, a number of previous reports suggest that intermolecular electrostatic CPP-cargo interactions as well as the strength of the interaction are essential in order to obtain CPP-mediated transepithelial permeation of a cargo peptide. [9] [10] [11] In addition, a recent study questions whether complex formation between insulin and penetratin is a necessity to obtain penetratin-mediated transepithelial insulin permeation. 12 That study demonstrated that despite using a pH higher than the pI of the cargo (namely pH 6.5 and 7.4) for induction of high levels of electrostatic interactions between insulin and the CPP, no transepithelial penetratin-mediated insulin permeation in vitro was evident. On the contrary, at pH 5, at which insulin-penetratin complexation did not dominate the sample, co-administration of penetratin with insulin significantly, and without signs of detrimental effects on the epithelial cells, improved the transepithelial insulin permeation when compared to insulin administered alone under the same conditions. Importantly, pH-lowering compounds are frequently implemented in drug delivery systems as a feasible strategy to improve the transmucosal delivery of peptide and protein-drug entities by limiting the enzymatic degradation at the absorption site [13] [14] [15] (reviewed in 16, 17 ); thus demonstrating the relevance of studying the impact of applying a slightly acidic pH for improving oral delivery.
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Thus, to mechanistically explain the influence of pH and administration approach, the aim of this study was to conduct in-depth investigations to explore cellular and membrane effects of applying pH 5 and 7.4 for penetratin-enhanced transepithelial PTH(1-34) permeation across epithelial cell layers; focusing on potentially associated toxic events induced by using the conjugation approach versus the co-administration approach.
RESULTS

CPP-mediated transepithelial PTH(1-34) permeation depends on administration approach and pH
Penetratin was successfully conjugated to PTH(1-34) 8 resulting in a molecule with higher molecular weight and pI than the PTH . The sequences, molecular weights, and pI values for PTH , penetratin, and the PTH(1-34)-penetratin conjugate are listed in Table 1 . PTH(1-34) conjugated to penetratin or co-administered with penetratin in a 1:1 molar ratio were evaluated for its ability to permeate Caco-2 cell monolayers at pH 7.4 or pH 5 in order to investigate the effect of lowering the pH . At pH 7.4, the co-administration approach was significantly more effective than the conjugation approach with respect to enhancing the transepithelial PTH(1-34) permeation ( Figure 1a ).
Lowering the pH of the PTH(1-34)-penetratin conjugate from 7.4 to 5 increased the PTH(1-34) permeation 3.1-fold and to the same level as if co-administered ( Figure 1b ) as also reflected in the calculated P app values ( 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 59 60 
Only for the conjugate, decreasing the pH negatively affects epithelial integrity and cellular viability
In order to evaluate the integrity of the Caco-2 cell monolayers and potential cytotoxicity resulting from exposure to PTH(1-34) and penetratin as either co-administered or conjugated, the TEER was determined before and after each permeation study (Figure 2a ), and the cellular viability was evaluated after each permeation study ( Figure 2b ).
Neither of the pH 7.4 samples affected the integrity of the epithelium or the cellular viability, whereas lowering the pH to 5 resulted in a significant decrease in both epithelial integrity and cellular viability as a result of incubation with the PTH(1-34)-penetratin conjugate. Thus, the observed increase in PTH permeation as a result of lowering the pH of the PTH(1-34)-penetratin conjugate from 7.4 to 5 (Figure 1 , 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   6   Table 2 ) can be ascribed to an effect on cell viability accompanied by partly disruption of the Caco-2 monolayer integrity (Figure 2a) . Surprisingly, no effect on neither the epithelial integrity (Figure 2a ) nor the cellular viability ( Figure 2b ) was observed as a result of co-administering PTH(1-34) with penetratin at pH 5. 
Real-time cellular viability kinetics differ according to pH and administration approach
The viability of proliferating Caco-2 cells incubated with PTH(1-34) conjugated to penetratin or coadministered with penetratin at pH 5 or 7.4 was monitored in real-time over 5 h using the RealTime-Glo 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 9
Measuring changes in impedance during incubation with various samples were achieved using the xCELLigence system, which allows label-free measurements in real-time, thus, eliminating potential adverse effects caused by a label or e.g. additional substrates necessary for a read-out. This approach was implemented in order to explore whether the cellular effects observed earlier with respect to lowering of TEER (Figure 2a ) and the cellular viability (Figure 2b In the present study, the CI of proliferating Caco-2 cells was monitored during a 26.5 h proliferation period followed by a 2 h sample incubation period and finally, a recovery period in cell culture medium for approximately 26 h ( Figure 5a ). Washing steps were included between each incubation period in order to ensure complete removal of cell medium and sample, respectively. The effect on the CI of the washing step before sample application is observed in Figure 5b between the first two time-points. Bioconjugate Chemistry   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 59 60 . Surprisingly, dramatic changes in the adhesive properties of Caco-2 cells exposed to penetratin alone at pH 5, but not at pH 7.4, were observed during the recovery phase ( Figure SI 3) . However, only a slight increase in Trypan Blue uptake was observed during incubation with penetratin alone at pH 5 when compared to pH 7.4 ( Figure SI 4) . Thus, the changes in adherence resulting from incubation with penetratin alone at pH 5 is not a result of cell death as was the case for incubation with the PTH(1-34)penetratin conjugate at pH 5 ( Figure 5 ).
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In order to obtain more detailed information about the changes in adherence indirectly observed based on the changes in the CI values using the xCELLigence system ( Figure 5 ), the morphology of the proliferating Caco-2 cells was evaluated by an optical approach using the oCelloscope setup ( 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 11
Assessing the cell morphology according to circularity (Figure 6b 
The folding propensity of the PTH(1-34)-conjugates upon membrane contact is not pH-dependent
Penetratin adapts an α-helical secondary structure in the vicinity of negatively charged lipid membranes, 18 which is furthermore believed to be of importance for its cell penetrating propensity. 19, 20 Thus, the ability of 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 59 60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 13
DISCUSSION
The aim of the present study was to investigate the cellular effect of applying CPPs as permeation enhancers for peptide transport across the intestinal epithelial barrier. Within this context, the influence of pH as well as administration approach, being co-administration or covalent conjugation, was evaluated using various methods.
A previous study investigating the effect of decreasing the pH from 7.4 to 5 of insulin co-administered with penetratin in a 1:4 molar ratio resulted in a 6-fold increase of insulin permeation across Caco-2 monolayers, whereas no effect was observed at pH 7.4. 12 At pH 7.4 the propensity of penetratin to enhance PTH(1-34) permeation across Caco-2 monolayers, when administered in a 1:1 ratio, was dependent on the administration approach applied with co-administration being more effective than conjugation (Figure 1a , Table 2 ); likely due to the larger molecular size of the conjugate. The outcome of the present study therefore, complements earlier results by concluding that both pH and the molar therapeutic protein or peptide to penetratin mixing ratio influences the penetratin-mediated transepithelial permeation of the former.
By lowering the pH from 7.4 to 5, covalent conjugates of penetratin to PTH(1-34) were as effective in mediating transepithelial PTH(1-34) permeation as if PTH(1-34) was co-administered with penetratin ( Figure 1b , Table 2 ). However, at pH 5 the PTH(1-34)-penetratin conjugate negatively affected the cellular viability (Figure 2a ) as well as the epithelial integrity (Figure 2b) . A recovery study demonstrated that after terminating the exposure to the PTH(1-34)-penetratin conjugate at pH 5 and subsequently, incubating the cells with cell medium, the epithelial integrity was restored when assessed after a 24 h ( Figure SI 1a) .
However, the TEER across the monolayers initially incubated with the PTH(1-34)-penetratin conjugate at pH 5 was 150 % compared to the buffer control when assessed after the 24 h recovery period. This significant increase in TEER is likely to be a stress-induced effect following incubation with and removal of the seemingly toxic pH 5 PTH(1-34)-penetratin conjugate, and may not necessarily reflect the integrity of healthy epithelial cells in a monolayer. This is well in line with the fact that the cellular viability was still significantly lower for the cells initially incubated with the PTH(1-34)-penetratin conjugate at pH 5 when compared to the buffer-treated control cells ( Figure SI 1b) .
It was previously demonstrated that covalent conjugation of an R9 sequence to PTH(1-34) negatively affected the viability of Caco-2 cells at pH 7.4, whereas co-administration of PTH(1-34) with the R9 sequence in similar concentrations did not affect the cellular viability. 8 In that study, it was speculated that the observed toxic effect was a result of the PTH(1-34)-R9 conjugate being longitudinal amphipathic.
In the present study, exposure to the PTH(1-34)-penetratin conjugate did not give rise to any adverse effects at pH 7.4 in accordance with findings in the previous study. 8 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 14 when compared to administration of Tat alone to HeLa or CHO cells; 21 possibly due to the fact that terminal conjugation of the highly positively charged Tat sequence (pI 12.3) results in longitudinal amphipathicity.
However, the negative effect on cellular viability resulting from conjugating a peptide cargo to Tat was in that study not observed as a result of cargo conjugation to penetratin, undecaarginine (R11), or transportan.
Thus, whether or not covalent conjugation of a peptide cargo to a CPP will negatively affect the cellular viability is dependent on multiple factors counting the specific CPP and cargo sequences, their concentrations, as well as the cell type and, as demonstrated in the present study, the pH of the formulation.
In order to elaborate on the negative effect on the cellular viability exerted by the PTH(1-34)-penetratin conjugate at pH 5 following incubation with well-differentiated Caco-2 monolayers (Figure 2b) , the viability of proliferating Caco-2 cells were followed using a real-time assay (Figure 3) , and compromised cells were visualized using Trypan Blue staining (Figure 4 ). Both assays supported the outcome of the MTS/PMS assay carried out after the transport study, demonstrating that the PTH(1-34)-penetratin conjugate at pH 5 has a greater negative effect on the cellular viability. In addition, it was clear that the kinetics of the cell viability differed both according to pH of the sample as well as the administration approach being covalent conjugation or co-administration ( Figure 3a) . A steeper increase in the luminescent signal was observed during incubation with PTH(1-34) co-administered with penetratin at pH 5 when compared to pH 7.4. Due to the fact that the Trypan Blue staining was also more pronounced for the co-administered sample at pH 5, as opposed to at pH 7.4 (Figure 4 ), the steep initial increase in the luminescent signal could in principle represent a stress-induced effect by the low pH. However, a similar steep initial increase in the luminescence was observed for the pH 7.4 buffer-treated control cells ( Figure SI 2) , and therefore, apparently reflect the state of non-compromised cells.
Morphological changes were studied using the xCELLigence system as well as the oCelloscope. In the xCELLigence study ( Figure 5 ), morphological changes were detected for cells during incubation with the PTH(1-34)-penetratin conjugates at pH 5 and PTH(1-34) co-administered with penetratin at pH 5, whereas almost no effect on the cell morphology was observed during incubation with the pH 7.4 samples ( Figure   5b ). A similar trend was observed during the post-recovery phase. Here, only a minor increase in CI was observed for cells exposed to PTH(1-34) co-administered with penetratin at pH 5, whereas a dramatic increase in CI was obvious for cells exposed to the PTH(1-34)-penetratin conjugate at pH 5 (Figure 5c ).
Hence, the incubation at pH 5 facilitates cell detachment from the solid support, and the extent to which this occurs, is highly dependent on whether penetratin is covalently conjugated to PTH(1-34) or co-administered with PTH(1-34). Interestingly, penetratin applied alone at pH 5 had a similar dramatic effect on the cell morphology during the post-recovery phase as observed for the cells subjected to incubation with the PTH(1-34)-penetratin conjugate at pH 5 ( Figure SI 3) . However, this post-recovery effect was only observed to a minor extent resulting from incubation with PTH(1-34) co-administered with penetratin at pH 5. Likely due to the fact that the interaction between penetratin and the cell membrane is hindered by competitive PTH(1- 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 15 34)-membrane interactions and/or e.g. hydrophobic interactions between PTH(1-34) and penetratin, thus, limiting the availability of penetratin to interact with the cell membrane. Morphological changes of the Caco-2 cells during the sample incubation phase were moreover assessed according to cell area and circularity using the oCelloscope ( Figure 6 ). Clear differences in both the cell area and the cell circularity were observed according to administration approach as well as pH. The most pronounced effect on the cell morphology was observed during incubation with the PTH(1-34)-penetratin conjugate at pH 5 resulting in smaller cell areas (Figure 6a ) and more circular cells (Figure 6b ) as compared to cells incubated with the PTH(1-34)-penetratin conjugate at pH 7.4 or PTH(1-34) co-administered with penetratin at pH 5 or 7.4.
Thus, the interaction between the proliferating Caco-2 cells with the PTH(1-34)-penetratin conjugate at pH 5 promotes a rounding up of the cells (Figure 6b ), thus, making them prone to detachment from the solid support as demonstrated using the xCELLigence system during the post-recovery period after sample replacement with cell medium (Figure 5c ).
Finally, in order to explain the pH-dependent penetratin-mediated PTH(1-34) permeation across the Caco-2 monolayer as well as effect on the cell viability only observed following incubation with the PTH(1-34)penetratin conjugate, but not following co-administration of PTH(1-34) with penetratin (Figure 1b, Figure 2) , CD spectroscopy and a calcein release assay was conducted employing the conjugates. Potential pHdependent structural changes of the PTH(1-34)-penetratin conjugate in the vicinity of lipid membranes was assessed using CD spectroscopy (Figure 7) , and its ability to disrupt lipid membranes at pH 5 and 7.4 was evaluated by a calcein release assay (Figure 8) . A recent study in which different amino acid analogues of the lipidated CPP PepFect 3 were used, demonstrated a direct correlation between the degree of α-helical content and the ability to perturb negatively charged lipid membranes for some, but not all CPPs. 22 This is in line with the outcome of the present study, demonstrating that the PTH(1-34)-penetratin conjugate adapted an αhelical structure, and that to the same extent, at both pH 5 and pH 7.4 ( Figure 7 ). However, the ability of the PTH(1-34)-penetratin conjugate to perturb lipid membranes was highly pH-dependent as demonstrated by the calcein release assay (Figure 8 ). Thus, the PTH(1-34)-penetratin conjugate is likely to be able to penetrate into lipid membranes, and a direct translocation mechanism may therefore account for the penetratin-mediated transepithelial PTH(1-34) permeation when applied as a conjugate (Figure 1 ).
Furthermore, this is more effective at the lower pH, at which the penetratin sequence bears the highest degree of positive charge. This result supported the outcome of the Caco-2 transport assay demonstrating an increase in PTH(1-34) permeation, when lowering the pH of the PTH(1-34)-penetratin conjugate to the pH at which the conjugate is most membrane active, i.e. being longitudinal amphipathic (Figure 1 ). On the other hand, the penetratin-mediated transepithelial PTH(1-34) permeation following co-administration may take place mainly via endocytic uptake following transcytosis due to the lack of the longitudinal amphipathicity.
Endocytic uptake has earlier been suggested to be the main mechanism driving the cellular internalization of penetratin and a number of additional CPPs. 23, 24 However, the conjugation of a cargo peptide to highly 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 16 positively charged CPPs adds longitudinal amphipathicity to the resulting molecule, which then acts on cell membranes in a detergent-like manner. Nevertheless, more focused mechanistic studies must be conducted in order to fully explain the mechanisms in play for the CPP-mediated transepithelial cargo delivery as a result of covalent conjugation or co-administration and variable pH.
CONCLUSIONS
In the present study the penetratin-mediated PTH ( Thus, from the present study it can be concluded that when applying highly positively charged CPPs as epithelial permeation enhancers for a peptide cargo, the covalent conjugation approach may, in synergy with a change in local pH, compromise the cells in the epithelium when the pH dictate full protonation of the CPP and thus, ensures longitudinal amphipathicity of the conjugate.
MATERIALS AND METHODS
Materials
Coupling reagents and rink amide resin for the synthesis of penetratin were obtained from Fluka (Buchs, Switzerland 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 TTTTTACGCAG. E. coli Mach1 cells (Life Technologies, Naerum, Denmark) were used for cloning with kanamycin (50 µg/mL) and chloramphenicol (35 µg/mL) (Sigma Aldrich, Buchs, Switzerland). The cells were grown in Terrific Broth (TB) medium (tryptone 12.0 g/L, yeast extract 24.0 g/L, K 2 HPO 4 9.4 g/L, 
PTH(1-34)-penetratin fusion peptide production and peptide synthesis
Expression constructs: The PTH(1-34)-penetratin fusion peptide was cloned, expressed and purified as previously described. 8 Penetratin was synthesized and purified as earlier described. 12
Cell culture model
Caco-2 cells were obtained from American Type Cell Cultures (ATCC, Manassas, VA, USA) and maintained as previously described 12 For impedance measurements with the xCELLigence system, 6×10 4 Caco-2 cells suspended in cell culturing medium were seeded in each well of a collagen-coated E-plate (ACEA Biosciences, San Diego, CA, USA) and incubated in the xCELLigence system (at 37°C and 5 % CO 2 ), and grown for 26.5 h.
In vitro transepithelial permeability
Test samples containing 40 µM PTH(1-34)-penetratin fusion peptide or equimolar concentration of PTH(1-34) in a physical mixture with penetratin were prepared in HBSS immediately before the experiment. The 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 18 solutions were either supplemented with 10 mM MES and adjusted to pH 5 (mHBSS) or with 10 mM HEPES and adjusted to pH 7.4 (hHBSS). The experiment was performed at 37°C and with horizontal shaking as previously described. 12 The Caco-2 cell monolayers were washed twice apical and basolateral with 37°C hHBSS and equilibrated to room temperature in hHBSS, before the transepithelial electrical resistance (TEER) was measured using an EVOM equipped with an Endohm-12 cup (World Precision Instruments, Sarasota, FL, USA After the permeation experiment, the epithelia were washed twice on the apical and basolateral sides with 37°C hHBSS and equilibrated to room temperature before the TEER was assessed in order to evaluate the effect on the monolayer integrity following sample incubation. All experiments were performed in triplicate each on 2-3 consecutive passages between number 5 and 20.
The apparent permeability coefficient (P app ) was calculated by using the equation: P app (cm/s) = dQ/dt × 1/(A × C 0 ) (Eq. 1)
where dQ/dt is the steady state flux, A (1.13 cm 2 ) is the area of the Caco-2 monolayer and C 0 is the initial donor concentration applied to the apical side of the cell monolayer.
Cellular viability and cytotoxicity
The MTS/PMS assay previously described by Cory et al 25 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 and A buffer is the absorbance of the negative control; i.e. cells incubated with buffer corresponding to 100 % cell viability. 
Cellular morphology and adherence real-time experiments
The morphology of Caco-2 cells cultured for 24 h were followed optically using the oCelloscope system 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 20 incubation in cell medium for an additional approximately 26 h. The experiment was performed in triplicate and the cell index (CI) was recorded over 55 h in total. CI = (Impedance at time point n -impedance in the absence of cells)/nominal impedance value (Eq. 3)
Liposome preparation
CD spectroscopy, unilamellar anionic POPC:POPG liposomes in a molar 80:20 ratio were produced by the thin film method as previously described by Foged et al. 26 For the calcein release assay, lipid films were prepared as described above, but hydrated in HEPES buffer containing 70 mM calcein before agitation and annealing. Excess calcein, not entrapped in the liposomes, were removed by passing the liposome suspension through four Sephadex G-50 columns (GE Healthcare, Broendby, Denmark) before the vesicle sizes were verified by DLS. where MRW is the mean residue molar weight, λ is the ellipticity in mdeg, d is the path length in cm, and C is the molar concentration. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 21 starting the measurement of the fluorescence intensity. The fluorescence was measured at 37°C on a POLARstar Optima plate reader (BMG Labtech, Offenburg, Germany) every 10 sec for 1 h with excitation and emission set at 485 nm and 520 nm, respectively. After the last measurement, 10 % (w/v) Triton X-100 was added as control for 100 % calcein release.
Peptide folding propensity
Percent encapsulated calcein was calculated for liposomes without added test samples by:
% encapsulated calcein = ((FaTX -FbTX)/FaTX)*100 % (Eq. 5)
where FaTX and FbTX is fluorescence after and before the addition of Triton X-100, respectively.
Percent calcein release was calculated as:
% calcein release = 100 -(% encapsulated at x min/% encapsulated at 0 min) (Eq. 6)
Data and statistical analysis
Microsoft Office Excel 2010 and GraphPad Prism version 7 (GraphPad Software, San Diego, CA, USA)
were employed for data processing. Statistical analysis was done in GraphPad Prism version 6 using one way analysis of variance (ANOVA) and two-way ANOVA. Data are presented as mean ± standard error of mean (SEM) or mean ± standard deviation (SD) with n representing the total number of replicates, and N representing the number of passages.
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ACS Paragon Plus Environment
